Raymond James & Associates’s First Trust Mid Cap Core AlphaDEX Fund FNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$24.2M Sell
206,664
-23,004
-10% -$2.59M 0.01% 720
2024
Q2
$24.9M Buy
229,668
+20,815
+10% +$2.27M 0.02% 665
2024
Q1
$23.7M Sell
208,853
-24,922
-11% -$2.63M 0.02% 697
2023
Q4
$24.4M Buy
233,775
+6,234
+3% +$585K 0.02% 646
2023
Q3
$21M Sell
227,541
-38,798
-15% -$3.75M 0.02% 662
2023
Q2
$25.7M Buy
266,339
+53,307
+25% +$4.8M 0.02% 589
2023
Q1
$19.2M Sell
213,032
-8,539
-4% -$790K 0.02% 695
2022
Q4
$19.5M Buy
221,571
+2,481
+1% +$219K 0.02% 683
2022
Q3
$17.6M Buy
219,090
+25,113
+13% +$2.24M 0.02% 664
2022
Q2
$16.2M Buy
193,977
+15,140
+8% +$1.39M 0.02% 718
2022
Q1
$17.5M Buy
178,837
+15,804
+10% +$1.54M 0.01% 763
2021
Q4
$16.8M Sell
163,033
-2,033
-1% -$208K 0.01% 835
2021
Q3
$16.1M Sell
165,066
-7,498
-4% -$747K 0.01% 819
2021
Q2
$17.3M Buy
172,564
+48,638
+39% +$4.77M 0.02% 787
2021
Q1
$11.6M Buy
123,926
+3,642
+3% +$330K 0.01% 941
2020
Q4
$9.99M Sell
120,284
-4,842
-4% -$366K 0.01% 949
2020
Q3
$8.25M Sell
125,126
-214,238
-63% -$14.1M 0.01% 960
2020
Q2
$21.2M Buy
339,364
+43,001
+15% +$2.46M 0.03% 494
2020
Q1
$14.3M Sell
296,363
-40,506
-12% -$2.63M 0.02% 581
2019
Q4
$24.4M Buy
336,869
+51,026
+18% +$3.57M 0.03% 497
2019
Q3
$19.3M Buy
285,843
+95,612
+50% +$6.49M 0.03% 559
2019
Q2
$13.1M Sell
190,231
-19,832
-9% -$1.35M 0.02% 724
2019
Q1
$14.1M Buy
210,063
+29,204
+16% +$1.91M 0.02% 658
2018
Q4
$10.5M Buy
180,859
+17,064
+10% +$1.09M 0.02% 733
2018
Q3
$11.7M Buy
163,795
+53,215
+48% +$3.79M 0.02% 755
2018
Q2
$7.57M Buy
110,580
+8,950
+9% +$604K 0.01% 958
2018
Q1
$6.65M Buy
101,630
+2,561
+3% +$171K 0.01% 988
2017
Q4
$6.51M Buy
99,069
+6,184
+7% +$395K 0.01% 988
2017
Q3
$5.75M Buy
92,885
+2,143
+2% +$128K 0.01% 1007
2017
Q2
$5.37M Sell
90,742
-47,840
-35% -$2.8M 0.01% 1002
2017
Q1
$8.1M Sell
138,582
-114,388
-45% -$6.64M 0.02% 789
2016
Q4
$14.3M Sell
252,970
-11,428
-4% -$618K 0.04% 488
2016
Q3
$14M Buy
264,398
+91,051
+53% +$4.78M 0.04% 465
2016
Q2
$8.76M Sell
173,347
-16,570
-9% -$829K 0.03% 594
2016
Q1
$9.43M Sell
189,917
-37,324
-16% -$1.71M 0.03% 546
2015
Q4
$10.9M Buy
227,241
+27,672
+14% +$1.38M 0.04% 491
2015
Q3
$9.6M Buy
199,569
+46,010
+30% +$2.36M 0.04% 491
2015
Q2
$8.28M Buy
153,559
+69,233
+82% +$3.81M 0.03% 589
2015
Q1
$4.6M Sell
84,326
-113,566
-57% -$6.03M 0.02% 783
2014
Q4
$10.5M Sell
197,892
-276,370
-58% -$14.2M 0.05% 390
2014
Q3
$23.8M Buy
474,262
+1,749
+0.4% +$91.4K 0.14% 157
2014
Q2
$25.3M Buy
472,513
+17,200
+4% +$882K 0.16% 126
2014
Q1
$23.4M Buy
455,313
+59,561
+15% +$2.99M 0.16% 127
2013
Q4
$20M Buy
395,752
+33,540
+9% +$1.61M 0.15% 143
2013
Q3
$16.6M Buy
362,212
+33,322
+10% +$1.49M 0.14% 142
2013
Q2
$13.9M Buy
+328,890
New +$13.9M 0.13% 162

Other funds holding FNX

Raymond James & Associates's FNX Position: Q3 2024 in Review

Raymond James & Associates reduced its First Trust Mid Cap Core AlphaDEX Fund (FNX) stake by 10% in Q3 2024, selling an estimated $2.59M and leaving 206,664 shares worth $24.2M. The position accounts for 0.01% of the portfolio, ranked #720.

Raymond James & Associates first reported a position in FNX in Q2 2013 and has held it in 46 quarters since. The position peaked at $25.7M in Q2 2023. 179 funds tracked by Wall St. Rank hold FNX as of Q3 2024.

  • Raymond James & Associates held 206,664 shares of First Trust Mid Cap Core AlphaDEX Fund worth $24.2M as of Q3 2024.
  • Raymond James & Associates sold 23,004 First Trust Mid Cap Core AlphaDEX Fund shares in Q3 2024, an estimated $2.59M.
  • First Trust Mid Cap Core AlphaDEX Fund made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #720 holding.
  • Raymond James & Associates first reported a position in First Trust Mid Cap Core AlphaDEX Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's First Trust Mid Cap Core AlphaDEX Fund position peaked at $25.7M in Q2 2023.
  • 179 funds tracked by Wall St. Rank held First Trust Mid Cap Core AlphaDEX Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.